Author: Zhyvotovska, Angelina; Yusupov, Denis; Foronjy, Robert; Nakeshbandi, Mohammed; McFarlane, Samy I; Salifu, Moro
Title: Insights into Potential Mechanisms of Injury and Treatment Targets in COVID-19, SARS-Cov-2 Infection Cord-id: pqzqu3mb Document date: 2020_6_8
ID: pqzqu3mb
Snippet: The severe acute respiratory syndrome coronavirus 2, SARS-CoV-2, is the most serious pandemic in modern times. The disease was first reported in January of 2020 in China’s city of Wuhan, Hubei province, and since then it has spread worldwide. Given the rapid spread of the virus and the burden it has taken on the healthcare systems it has swept through, there is the need for a concise description of current understanding of the pathogenesis of organ failure in SARS-CoV-2 infection while acknowl
Document: The severe acute respiratory syndrome coronavirus 2, SARS-CoV-2, is the most serious pandemic in modern times. The disease was first reported in January of 2020 in China’s city of Wuhan, Hubei province, and since then it has spread worldwide. Given the rapid spread of the virus and the burden it has taken on the healthcare systems it has swept through, there is the need for a concise description of current understanding of the pathogenesis of organ failure in SARS-CoV-2 infection while acknowledging that more is yet to be uncovered. This review will not only inform decision making at the bedside but will also help illustrate potential therapeutic targets for research. We searched the available literature to-date, and present the pathophysiology underlying increased morbidity and mortality of SARS-CoV-2 infection in the lungs, heart and kidneys in a highly illustrated presentation that is easy-to-understand for the clinician, researcher, and student alike.
Search related documents:
Co phrase search for related documents- acei angiotensin and acute aki kidney injury: 1, 2
- acei angiotensin and acute ards respiratory distress syndrome: 1, 2
- acei angiotensin and administration cell: 1
- acei angiotensin and lung alveolar: 1
- acei angiotensin and lung injury: 1, 2, 3, 4, 5
- acei angiotensin and lung kidney: 1, 2, 3
- acei angiotensin type and administration cell: 1
- acei angiotensin type and lung injury: 1
- acute aki kidney injury and adaptive immunity: 1
- acute aki kidney injury and lung alveolar: 1, 2, 3
- acute aki kidney injury and lung alveolar type ii cell: 1
- acute aki kidney injury and lung injury: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15
- acute aki kidney injury and lung kidney: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14
- acute aki kidney injury and lung perfusion: 1
- acute aki kidney injury and lung protective ventilation: 1
- acute aki kidney injury and lung tissue: 1, 2, 3, 4
- acute aki kidney injury and lung transplantation: 1, 2
- acute aki kidney injury and lymphocyte count: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19
- acute aki kidney injury incidence and adaptive immunity: 1
Co phrase search for related documents, hyperlinks ordered by date